Amphastar stock hits 52-week low of $34.85 amid market challenges Investing.com

In a turbulent market environment, Amphastar Pharmaceuticals Inc. (NASDAQ: ) stock touched a 52-week low, dipping to $34.85. Despite generating solid revenue growth of 20% and maintaining a healthy P/E ratio of 10.8, the stock appears undervalued according to InvestingPro…